TMDX: TransMedics Group, Inc.
Performance
TMDX -21.30%
Watchlist
Select an item
Summary
TMDX at a glance
TMDX returned -21.30% over the past year and +24.32% a year over five years. Its worst drop in that year was -58.76%, smaller than 14% of stocks on Redstone, and its Sharpe ratio of -0.11 beats 23% of stocks on Redstone. It pays no dividends.
Current Drawdown
-37.65%
Rolling Volatility
110.79%
Actions
Metrics
Risk Indicators
Alpha-19.79%
Beta1.27x
Sharpe-0.11
Sortino-0.17
Omega0.98
Calmar-0.36
Martin-0.20
Profile
About TMDX
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage.
- Sector
- Health Care
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Market cap
- $3.3B
- Listed
- May 2019
- Employees
- 898
- Headquarters
- Andover, MA
- Website
- transmedics.com
Comparisons